Home

Press Releases

Inaugural Event to Showcase Biotechnology Investment Opportunities at BIO Mid-America VentureForum Conference
Mar 6 2003
House Cloning Legislation May Stall New Medical Research
Feb 28 2003
Gilead, Trimeris and Serono Honored with<br>James D. Watson Helix 2003 Award
Feb 27 2003
Three New Media Briefings Added To BIO's CEO & Investor Conference
Feb 21 2003
Final Day of Advance Media Registration for BIO’s CEO & Investor Conference 2003
Feb 14 2003
BIO Statement on the Death of Dolly, the Cloned Sheep
Feb 14 2003
James D. Watson Helix 2003 Award to be Presented at BIO CEO and Investor Conference
Feb 12 2003
Industry Experts on Drug Development and Genetic Testing Announced for BIO’s CEO & Investor Conference
Feb 11 2003
BIO Statement: Anti-Cloning Bill Deserves Support
Feb 5 2003
BIO Statement: Anti-Cloning Bill Deserves Support
Feb 5 2003
BIO’s CEO Conference Highlights Economic Potential of Biotech Industry
Feb 4 2003
BIO Calls for Restoration of Medicare Drug Coverage
Jan 29 2003
BIO Board Member and CEO of Alkermes Richard F. Pops, To Testify On Medicare Issues
Jan 29 2003
BIO CEO & Investor Conference 2003 Media Registration Now Available Online
Jan 28 2003
FDA Commissioner McClellan To Speak at BIO CEO Conference
Jan 28 2003
New BIO Science and Regulatory Department to be headed by Dr. Gillian R. Woollett
Jan 24 2003
BIO Introduces Financial Community to Industrial Biotechnology
Jan 22 2003
FDA Approves 20 New Biotech Products, 15 New Indications
Jan 9 2003
The Third Wave of Biotechnology –Industrial- Investor Briefing Scheduled
Jan 8 2003
BIO Statement on Human Cloning
Dec 27 2002
Medicare Patients Face a New Year With Yesterday&#8217;s Medicines
Dec 18 2002
BIO Announces First Annual Industrial Biotechnology Analyst and Investor Briefing
Dec 17 2002
BIO Names Kathy Stover as New Communications Director
Dec 16 2002
Web Cast of BIO/Gates Foundation Global Health Forum Available
Dec 10 2002
BIO/Gates Foundation Global Health Forum Starts Tomorrow
Dec 3 2002